SEC Filing Summary: New York City REIT, Inc.
Business Context and Reporting Period
This Form 8-K was filed by New York City REIT, Inc. (not American Strategic Investment Co.) on November 15, 2022. The filing serves as a Regulation FD disclosure regarding a conference call held on the same date to discuss financial and operating results for the quarter ended September 30, 2022. The company is a Maryland corporation listed on the New York Stock Exchange under the symbol "NYC."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notice that an earnings call transcript (Exhibit 99.1) contains the detailed financial discussion for the third quarter of 2022.
Material Changes and Disclosures
- Financial Restatements: The company disclosed that it had to restate or revise certain historical financial statements.
- Internal Controls: A material weakness in internal controls has been identified.
- Recent Filings: The company filed an Amendment No. 1 to its June 30, 2022, Form 10-Q and its September 30, 2022, Form 10-Q on November 14, 2022, which likely contain the corrected financial data.
Outlook, Risks, and Contingencies
Management highlighted several forward-looking risks that could materially affect future results:
- Geopolitical and Health Risks: Adverse effects from the global COVID-19 pandemic and geopolitical instability due to the conflict between Russia and Ukraine, including sanctions and economic impacts.
- Acquisition Risks: Potential future acquisitions are subject to market conditions and capital availability and may not be completed on favorable terms.
- Legal Disclaimer: The information in this 8-K and the attached transcript is deemed "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the same liabilities as filed financial statements.
Investor Verification Checklist
- Review the Amended Form 10-Q for the period ended June 30, 2022 and the Form 10-Q for the period ended September 30, 2022 (both filed November 14, 2022) for accurate financial figures.
- Examine Exhibit 99.1 (the earnings call transcript) for specific commentary on the restatements and the material weakness in internal controls.
- Verify the company's current liquidity position and debt covenants given the history of financial restatements.
- Monitor updates regarding the remediation of the identified material weakness in internal controls.